|
|
Article: Eon Labs Receives the Second Approval for Dextroamphetamine and Amphetamine Mixed Salts.
- Article from:
- Business Wire
- Article date:
- June 17, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Medical Writers
NEW YORK--(BUSINESS WIRE)--June 17, 2002
Eon Labs, Inc. announced today that they received final approval for the generic alternative for the ADHD treatment, Adderall(R), (a).
The brand had sales of nearly $500 million in 2001, (b). Eon Labs is only the second generic manufacturer to receive approval for Dextroamphetamine and Amphetamine Mixed Salts. This is Eon Labs 7th approval in calendar 2002.
Eon Labs Vice President of Sales and Marketing, Frank Della Fera, R.Ph. said, "Since Eon is only the second generic player, we expect Amphetamine Mixed Salts to be an extremely important addition to our ...
Related newspaper, magazine, and journal articles:
|
|
Article: Eon Labs Receives Favorable District Court Ruling ...
Business Wire;
July 30, 2004 ;
656 words
...LAURELTON, N.Y. -- Eon Labs, Inc. (Nasdaq: ELAB ... for the Eastern District of New York granted judgment in favor of Eon Labs ruling that, while the validity ... prior to the trial preventing Eon Labs from selling Itraconazole ...
|
|